Carlo Maria Scornajenghi

About

Dr. Carlo Maria Scornajenghi is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for prostate cancer, particularly through robotic-assisted and laparoscopic approaches. His major contributions center on comparative effectiveness research, where he has rigorously evaluated the real-world outcomes of robotic-assisted radical prostatectomy (RARP) versus traditional laparoscopic radical prostatectomy (LRP). In his landmark 2024 study, cited 5 times, Dr. Scornajenghi demonstrated that in a single-surgeon, single-center setting, RARP offers superior oncological and functional results compared to LRP, providing critical evidence for surgical decision-making. He has also emerged as a leading voice in the adoption of cutting-edge technology, authoring a 2025 systematic review on the da Vinci Single-Port (SP) system in Europe—the first comprehensive analysis of this novel platform following its 2024 European approval. With over 9 citations across his most influential works, Dr. Scornajenghi’s research directly shapes clinical practice by offering data-driven insights into surgical innovation, patient outcomes, and the future of robotic urology.

Research Focus

Key Achievements

Top Papers

1. 1
   Real-Life Comparative Analysis of Robotic-Assisted Versus Laparoscopic Radical Prostatectomy in a Single Centre Experience

   5 citations · 2024
2. 2
   Da Vinci Single-Port Robotic Surgery in Europe: Where Do We Stand? A Systematic Review

   2 citations · 2025
3. 3
   Real Life Comparative Analysis of Robotic Assisted versus Laparoscopic Radical Prostatectomy in a Single Centre and Single Surgeon Experience

   2 citations · 2024

Key Collaborators

Contact & Links